---
title: "英偉達持倉概念股集體上漲，Recursion Pharmaceuticals 漲超 12%，文遠知行漲超 7%，CoreWeave 漲超 4%。"
description: "英偉達持倉概念股集體上漲，Recursion Pharmaceuticals 漲超 12%，文遠知行漲超 7%，CoreWeave 漲超 4%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261283559.md"
published_at: "2025-10-15T14:07:53.000Z"
---

# 英偉達持倉概念股集體上漲，Recursion Pharmaceuticals 漲超 12%，文遠知行漲超 7%，CoreWeave 漲超 4%。

英偉達持倉概念股集體上漲，Recursion Pharmaceuticals 漲超 12%，文遠知行漲超 7%，CoreWeave 漲超 4%。

### Related Stocks

- [NVDA.US - 英偉達](https://longbridge.com/zh-HK/quote/NVDA.US.md)
- [RXRX.US - Recursion Pharmaceuticals](https://longbridge.com/zh-HK/quote/RXRX.US.md)
- [WRD.US - 文遠知行](https://longbridge.com/zh-HK/quote/WRD.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Tranquility Partners LLC Has $8.60 Million Holdings in NVIDIA Corporation $NVDA | Tranquility Partners LLC increased its holdings in NVIDIA Corporation (NASDAQ: NVDA) by 10% in Q3, owning 46,069 shares  | [Link](https://longbridge.com/zh-HK/news/275589681.md) |
| WeRide Just Hit the Roads in Dubai. Should You Buy WRD Stock Now? | WeRide Just Hit the Roads in Dubai. Should You Buy WRD Stock Now? | [Link](https://longbridge.com/zh-HK/news/269896363.md) |
| Nvidia Stock Forecast Gets a Boost? Top Analyst Turns More Bullish Ahead of Q4 Earnings | Nvidia (NVDA) stock received a boost from UBS analyst Timothy Arcuri, who raised his price target to $245 from $235 ahea | [Link](https://longbridge.com/zh-HK/news/275702966.md) |
| Prediction: This AI Stock Will Soar After Feb. 25. Here's Why. | Nvidia (NVDA) shares have faced a 2% decline over the past three months due to geopolitical tensions and concerns about  | [Link](https://longbridge.com/zh-HK/news/275701772.md) |
| NVIDIA Corporation $NVDA Stock Holdings Decreased by Simplicity Wealth LLC | Simplicity Wealth LLC reduced its holdings in NVIDIA Corporation (NASDAQ:NVDA) by 31.0% in Q3, now owning 220,979 shares | [Link](https://longbridge.com/zh-HK/news/275589676.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。